The laboratory indicators of hypercoagulability in COVID-19 correlate with the overproduction of the inflammatory markers (interleukin-6 and -8, fibrinogen, CRP) and cells (neutrophilia and monocytosis). The gene discussed is IL6; the disease is thrombophilia.